Protect Patients from Costly Care: Medicaid and Orphan Drug Changes.
This bill aims to reverse changes that could have increased healthcare costs for individuals using Medicaid. Additionally, it restores previous rules regarding orphan drugs within the drug price negotiation program, potentially impacting the availability and pricing of medications for patients with rare diseases.
Key points
Reverses changes to Medicaid cost-sharing requirements, potentially lowering out-of-pocket expenses for patients.
Repeals changes to the exclusion for orphan drugs in the Medicare Drug Price Negotiation Program, which could lead to lower drug prices.
Status:
Introduced
Civic Will
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.